$5.68
-0.40-6.58%
Ult. Agg.: Oct 7, 7:59 PM
$6.99
0.9115%
Profound Medical (PROF) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Profound Medical (PROF) ha pubblicato l'ultima guidance il ottobre 7, 2026 per Q3 2026. La società ha previsto un fatturato pari a $9.8M - $10M per il periodo.
Rispetto alle previsioni precedenti, Profound Medical {{epsDirection}} ha modificato le sue previsioni di fatturato da un intervallo precedente di {{epsPriorRange}}.
Profound Medical ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Profound Medical. 10
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-0.25 | $-0.27 | $-0.38 |
| Actual | $-0.26 | $-0.19 | $-0.27 | $-0.26 |
| Surprise | -8.33% | +24.0% | 0.00% | +31.6% |
| Revenue | ||||
| Estimate | $6.3M | $6.3M | $9.4M | $7.1M |
| Actual | $2.5M | $5.3M | $6.0M | $5.3M |
| Surprise | -60.8% | -15.8% | -36.3% | -25.3% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.23 | $-0.19 | $-0.20 | $-0.20 |
| Revenue | ||||
| Consensus | $8.9M | $13.0M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.26 | $-0.24 | -8.33 % |
| Q1 | May 7, 2026 | $-0.19 | $-0.25 | 24.0 % |
| Q4 | Mar 5, 2026 | $-0.27 | $-0.27 | 0.00 % |
| Q3 | Nov 13, 2025 | $-0.26 | $-0.38 | 31.6 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $2.48M | $6.34M | -60.8 % |
| Q1 | May 7, 2026 | $5.34M | $6.34M | -15.8 % |
| Q4 | Mar 5, 2026 | $5.98M | $9.38M | -36.3 % |
| Q3 | Nov 13, 2025 | $5.29M | $7.08M | -25.3 % |